Cytek Biosciences to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference
Cytek Biosciences to Participate at the Goldman Sachs 45th Annual Global Healthcare Conference
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Cytek's novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek's FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the flow cytometer and imaging products under the Amnis and Guava brands; the Cytek Orion reagent cocktail preparation system, and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek headquarters are in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, FL.
加州弗裏蒙特，2024年5月30日（環球新聞社)- Cytek Biosciences，Inc.（納斯達克： CTKB）是一家領先的細胞分析解決方案公司，今天宣佈該公司將參加即將在佛羅里達州邁阿密海灘舉行的高盛第45屆全球醫療保健大會。thCytek管理層計劃於6月12日星期三上午9:20參加“爐邊聊天”。東部時間/太平洋時間城市感興趣的各方可以在公司網站的“投資者”部分訪問演示文稿的實時和存檔網絡廣播：investors.cytekbio.com。
Cytek management is scheduled to participate in a fireside chat on Wednesday, June 12th at 9:20 a.m. Eastern Time / 6:20 a.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company website at: investors.cytekbio.com.
關於Cytek Biosciences，Inc.thCytek Biosciences（納斯達克： CTKB）是一家領先的細胞分析解決方案公司，通過使用其專利的全光譜分析（FSP）技術提供高分辨率、高內容和高靈敏度的細胞分析，推動下一代細胞分析工具的發展。Cytek的新方法利用發光信號整個光譜內的信息，以實現更高水平的多重檢測精度和敏感度。 Cytek的FSP平台包括其核心儀器Cytek Aurora和Northern Lights系統；其細胞分選機Cytek Aurora CS；Amnis和Guava品牌下的流式細胞儀和成像產品；Cytek Orion試劑混合製備系統以及試劑、軟件和服務，爲其客戶提供綜合集成的解決方案套件。 Cytek總部位於加利福尼亞弗裏蒙特，並在全球範圍內設有辦事處和分銷渠道。有關該公司及其產品的更多信息，請訪問www.cytekbio.com。
About Cytek Biosciences, Inc.
Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Cytek's novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek's FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the flow cytometer and imaging products under the Amnis and Guava brands; the Cytek Orion reagent cocktail preparation system, and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek headquarters are in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.
Cytek Biosciences（納斯達克： CTKB）是一家領先的細胞分析解決方案公司，通過使用其專利的全光譜分析（FSP）技術提供高分辨率、高內容和高靈敏度的細胞分析，推動下一代細胞分析工具的發展。Cytek的新方法利用發光信號整個光譜內的信息，以實現更高水平的多重檢測精度和敏感度。 Cytek的FSP平台包括其核心儀器Cytek Aurora和Northern Lights系統；其細胞分選機Cytek Aurora CS；Amnis和Guava品牌下的流式細胞儀和成像產品；Cytek Orion試劑混合製備系統以及試劑、軟件和服務，爲其客戶提供綜合集成的解決方案套件。 Cytek總部位於加利福尼亞弗裏蒙特，並在全球範圍內設有辦事處和分銷渠道。有關該公司及其產品的更多信息，請訪問www.cytekbio.com。
Cytek's products are for research use only and not for use in diagnostic procedures (other than Cytek's Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union).
Cytek的產品僅供研究使用，不用於診斷程序（除了中國和歐盟的Cytek Northern Lights-CLC系統和某些試劑可用於臨床使用）
Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Amnis and Guava are trademarks of Cytek Biosciences, Inc.
Cytek，Full Spectrum Profiling，FSP，Cytek Aurora，Northern Lights，Cytek Orion，Amnis和Guava是Cytek Biosciences，Inc的商標。
In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek's website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.
除了向美國證券交易委員會（SEC）提交的文件，新聞稿，公開電話會議和網絡廣播外，Cytek還使用其網站（www.cytekbio.com），LinkedIn頁面和X（以前是Twitter）帳戶作爲公司，產品的信息發佈渠道，計劃的財務和其他公告，參加即將到來的投資者和行業會議以及其他事項。此類信息可能被視爲重要信息，Cytek可以使用這些渠道以遵守其在FD（法規FD）下的披露義務。因此，投資者應該監視Cytek的網站，LinkedIn頁面和X帳戶，同時關注它的SEC文件，新聞發佈，公開電話會議和網絡廣播。
Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com
媒體聯繫人：
Stephanie Olsen
Lages＆Associates
（949）453-8080
stephanie@lages.com
Investor Contact:
Paul Goodson
Head of Investor Relations
Cytek Biosciences
pgoodson@cytekbio.com
投資者聯繫人：
Paul Goodson
投資者關係主管
Cytek Biosciences
pgoodson@cytekbio.com